纳米片在性结肠炎中的抗炎机制:冠状蛋白,GP130相互作用和转录基因特征
Dingyi Shen1, Li Gong2, Wei Yang1
1Guangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agriculture University, Guangzhou, Guangdong, 510642, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|June 30, 2025
概括
纳米片 (SeNSs) 通过减少炎症和组织损伤,显示出治疗性结肠炎 (UC) 的前景. 这些纳米材料为炎症性肠病提供了更安全,更有效的治疗策略.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,治疗选择有限.
- 目前针对UC的抗炎疗法具有低于最佳的疗效和不良影响.
- 需要更安全,更有效的治疗药物来治疗UC.
研究的目的:
- 研究纳米片 (SeNSs) 作为性结肠炎的新型治疗剂的潜力.
- 阐明SeNSs在UC中的抗炎作用的潜在机制.
主要方法:
- 进行了蛋白质组和转录组分析,以了解SeNS-巨细胞相互作用和信号通路调制.
- 一种硫酸 (DSS) 诱导的UC小鼠模型被用来评估SeNS在体内的疗效.
- 评估了关键的炎症标志物 (IL-1β,IL-6,TNF-α) 和疾病活性.
主要成果:
- 巨细胞将SeNS内部化,调节AKT/PI3K和NF-κB信号通路中的蛋白质.
- SeNSs抑制了GP130的表达,降低了关键的炎症信号级联.
- 在体内研究表明,SeNSs降低了炎症性细胞因子水平,减轻了结肠组织损伤,并在DSS诱导的UC小鼠中降低了疾病活性指数.
结论:
- 纳米薄膜 (SeNSs) 具有显著的抗炎性质和性结肠炎的治疗潜力.
- 这种SENs调节巨细胞的行为和关键的炎症通路,为管理炎症疾病提供了一个有前途的新策略.
- SeNS的生物相容性和低毒性使其成为UC治疗的安全有效替代品.
更多相关视频
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
243
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
243
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
704
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
704
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
599
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
599
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
01:30Peptic Ulcer Disease I: Introduction
301
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
301
01:28Peptic Ulcer Disease II: Pathophysiology
885
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
885